RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00053143.xml
PDF herunterladen
CC BY 4.0 · Chinese medicine and natural products 2022; 02(04): e193-e199
DOI: 10.1055/s-0042-1759767
DOI: 10.1055/s-0042-1759767
Review Article
Reflections on the Application of Chinese Medicine During the Epidemic of COVID-19
Authors
Funding This work was supported by the National Natural Science Foundation of China (81373790 and 80973596) and Henan Science and Technology Project (182102310263).
Abstract
Traditional Chinese medicine (TCM) has played an important role in the prevention and control of coronavirus disease 2019 (COVID-19) and has received considerable attention from all sectors of society. In the current situation of the global outbreak, it is crucial to promote the global application of TCM. However, the pandemic has also exposed various problems affecting the widespread acceptance of TCM. In this review, we summarize efforts to prevent and control COVID-19 by TCM and provide strategic guidance on how to promote its practice in the context of public health emergencies by (1) completing the system for evaluating the clinical efficacy of TCM; (2) transforming decoctions into Chinese patent medicines; (3) encouraging low-threshold traditional rehabilitation therapy; (4) strengthening communication and cooperation with the media. The aim of these approaches is to improve the rigor of TCM research and its dissemination, sharing the antiepidemic experience of TCM to the world, as well as increase the engagement of and acceptance by the masses. In this manner, TCM will not only aid in preventing and controlling COVID-19 but can also provide tools for coping with future public health emergencies.
CRediT Authorship Contribution Statement
Shaohui Geng: Conceptualization, visualization, writing -original draft. Hanlin Shi, Shuangqing Yang, and Yaoyang Li: Visualization, data curation. Haixu Jiang, Heng Xu, Hesong Wang, and Zhiming Li: Investigation, data curation. Liping Yang: Supervision, writing-review & editing.
Publikationsverlauf
Eingereicht: 14. Juli 2022
Angenommen: 27. September 2022
Artikel online veröffentlicht:
30. Dezember 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Chan JF, Yuan S, Kok KH. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395 (10223): 514-523
- 2 Li Q, Guan X, Wu P. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382 (13) 1199-1207
- 3
Xu Z,
Shi L,
Wang Y.
et al.
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med 2020; 8 (04) 420-422
Reference Ris Wihthout Link
- 4 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
- 5 Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395 (10223): 470-473
- 6 World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March. Accessed November 22, 2022 at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020
- 7 World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Accessed November 22, 2022 at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
- 8 World Health Organization. WHO to accelerate research and innovation for new coronavirus. Accessed November 22, 2022 at: https://www.who.int/news-room/detail/06-02-2020-who-to-accelerate-research-and-innovation-for-new-coronavirus
- 9 Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020; 14 (01) 69-71
- 10 Ding SY, Wang QG, Lin MX. Enlightenment of Ancient and Modern Chinese Medicine Literature on Prevention and Treatment of New Coronavirus Pneumonia. J Tradit Chin Med 2020; 61 (16) 1397-1400
- 11 Lu ZZ, Lu XS. “Qingfei Paidu Decoction” highlights the efficacy and confidence of Chinese medicine in anti-epidemic. J Tradit Chin Med 2020; 61 (10) 833-834
- 12 Xia W, An C, Zheng C. et al. Clinical study on 34 cases of new coronavirus pneumonia treated by integrative traditional Chinese and Western medicine. J Tradit Chin Med 2020; 61: 375-382
- 13 Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008; 372 (9654): 1938-1940
- 14 Tsang IK. Establishing the efficacy of traditional Chinese medicine. Nat Clin Pract Rheumatol 2007; 3 (02) 60-61
- 15 Zhao C, Liu Z, Lin J, Wang YP, Wang YY, Shang HC. Standardizing individualized efficacy evaluation to optimize evidence-using pattern in traditional Chinese medicine—preliminarily establishing traditional Chinese medicine evidence-based case reporting system. World J Tradit Chin Med 2016; 2 (04) 49-54
- 16 Hu J, Liu S, Liu W, Zhang H, Chen J, Shang H. Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials. Ann Transl Med 2017; 5 (21) 420
- 17 Zhan ZL, Liu J, Yang W. et al. Exploratory study on evaluation criteria of therapeutic effect of traditional chinese medicine on new coronavirus pneumonia based on case analysis. J Tradit Chin Med 2020; 61 (12) 1013-1023
- 18 Zhang XY, Zhao C, Sun Y. et al. Promoting the establishment of a mechanism for collaboration and sharing of clinical trials: strategic thinking in the epidemic spreading period. J Tradit Chin Med 2020; 61 (08) 650-654
- 19 Yuan WA, Hu YY, Tang JY. et al. Insights into current clinical research of Chinese medicine in coronavirus disease 2019. Shanghai J Tradit Chin Med 2020; 1-5
- 20 Wang H, Jin XY, Pang B. et al. Analysis on clinical study protocols of traditional Chinese medicine for novel coronavirus pneumonia. Zhongguo Zhongyao Zazhi 2020; 45 (06) 1232-1241
- 21 National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on Issuance of a New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Seventh Edition). Accessed November 22, 2022 at: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml
- 22 National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on Issuance of a New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Sixth Edition). Accessed November 22, 2022 at: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml
- 23 National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on Issuance of a New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Fifth Edition). Accessed November 22, 2022 at: http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml
- 24 National Health Commission of the People's Republic of China. Notice of the General Office of the National Health Commission on the Issuance of a New Coronavirus Pneumonia Prevention and Control Program (Trial Fourth Edition). Accessed November 22, 2022 at: http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4.shtml
- 25 National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on Issuance of a Pneumonia Diagnosis and Treatment Scheme for New Coronavirus Infections (Trial Fourth Edition). Accessed November 22, 2022 at: http://www.gov.cn/zhengce/zhengceku/2020-01/28/content_5472673.htm
- 26 National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on Issuance of a Pneumonia Diagnosis and Treatment Scheme for New Coronavirus Infections (Trial Third Edition). Accessed November 22, 2022 at: http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml
- 27 People's Daily. Shuanghuanglian can inhibit the new coronavirus. Accessed November 22, 2022 at: https://m.weibo.cn/status/4466929533834665
- 28 Newman DJ. Modern traditional Chinese medicine: Identifying, defining and usage of TCM components. Adv Pharmacol 2020; 87: 113-158
- 29 Zhuang Y, Xie BT, Xie YM, Weng SX. [Research and implementation of adverse reaction automatic warning algorithm on Chinese medicine injection]. Zhongguo Zhongyao Zazhi 2012; 37 (18) 2695-2697
- 30 Stegelmeier BL, Brown AW, Welch KD. Safety concerns of herbal products and traditional Chinese herbal medicines: dehydropyrrolizidine alkaloids and aristolochic acid. J Appl Toxicol 2015; 35 (12) 1433-1437
- 31 Cai P, Qiu H, Qi F, Zhang X. The toxicity and safety of traditional Chinese medicines: Please treat with rationality. Biosci Trends 2019; 13 (05) 367-373
- 32 National Administration of Traditional Chinese Medicine. Notice on Issuing Guidance Recommendations for Traditional Chinese Medicine Rehabilitation in Recovery Period of New Coronavirus Pneumonia (Trial Implementation). http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-23/13319.html
- 33 Sok SR, Erlen JA, Kim KB. Effects of acupuncture therapy on insomnia. J Adv Nurs 2003; 44 (04) 375-384
- 34 Wu GC, Cao XD. [History and causes of acupuncture advancing towards the world]. J Chin Integr Med 2003; 1 (04) 247-251
- 35 Wang HC, Deng LY, Liu BY. [History of World Federation of Acupuncture-Moxibustion Societies]. Zhongguo Zhenjiu 2014; 34 (12) 1235-1237
- 36 HAO C. LIU F Q. Progress on cause of adverse reaction of traditional Chinese medicine. J Pharm Res 2017; 36 (06) 369-372
- 37 People.cn. Jiangxia Fangbin Hospital of Wuhan: Full Coverage of TCM Treatment. http://hb.people.com.cn/n2/2020/0305/c194063-33853070.html
- 38 Fang L, Zhu QG, Cheng W. et al. Retrospective analysis on 308 cases of COVID-19 and clinical application program of Kangyi Qiangshen Gong exercise prescription. Shanghai J Tradit Chin Med 2020; 54: 1-6
- 39 Yu XY, Tang SL, Wang GL. Study on preventive health care service in Traditional Chinese Medicine and policies under the concept of disease prevention theory. Chin J Heal Policy 2015; 8 (02) 71-75
- 40 Huang MA, Zhou YL, Chen D. Research on availability and optimal strategy of TCM service in the new rural cooperative medical system. Lishizhen Med Mater Med Res 2015; 26 (11) 2726-2728
- 41 Deng M. Analysis on promotion policy of TCM in primary health care based on the cognitive differences of consumer. Chin J Soc Med 2016; 33 (02) 113-116
- 42 Liu YH, Yu YW. Current situation and countermeasure suggestions of traditional Chinese medicine culture dissemination in the new media age. Public Comm Sci Technol 2019; 11: 174-176
- 43 China News Network. The tension of patients with Xinguan pneumonia was alleviated after taking TCM. Accessed November 22, 2022 at: https://m.weibo.cn/status/4471979253458522
- 44 People's Daily. Inhibition is not equal to prevention and treatment! Special reminder: Do not rush to take Shuanghuanglian oral liquid by yourself. Accessed November 22, 2022 at: https://m.weibo.cn/status/4467060161289290
- 45 Qian MJ, Zhang ZM. Curent situation and reflection on Chinese medicine reports in mainstream TV media of Australia. J Nanjing Univ of Tradit Chin Med 2019; 20: 20-24 (Social Science Edition)
- 46 Zhang LP. Study on the ecology of mass communication of traditional Chinese Medicine Culture under the background of new media. Chin Med Culture 2017; 12: 4-10